Skip to main navigation
  • About Us
    • Our Story
    • Our Leaders
    • Corporate Responsibility
    • Global Healthcare Gateway
    • Public Policy
    • Corporate Governance
    • Contact Us
  • Products
    • Therapeutic Areas
    • Brands
    • Generics
    • Biosimilars
    • Over-the-Counter
    • API
  • Newsroom
    • Press Releases
    • Stories and Viewpoints
    • Research and Reports
    • Media Resources
  • Careers
    • Working at Viatris
    • Diversity and Inclusion
    • Locations Near You
    • Search Careers
    • Careers FAQs
  • Investors
    • Events and Presentations
    • Financials and Filings
    • Stock Information
    • Shareholder Toolkit
    • Investor FAQs
Show Menu
Change LocationEn
Choose Your Location
  • Australia
  • Austria
  • Belgium
    • Dutch
    • French
  • Brazil
    • Bulgaria
    • Canada
      • English
      • French
    • China
    • Croatia
    • Czech Republic
    • Denmark
    • France
    • Germany
    • Greece
    • Hong Kong
      • English
      • Chinese
    • Hungary
    • India
    • Ireland
    • Italy
    • Japan
    • Korea
    • Malaysia
    • Netherlands
    • New Zealand
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland
      • German
      • French
    • Taiwan
    • Thailand
    • Turkey
    • United Kingdom
    • United States

    Localized information for

    The page you are about to visit contains information about Viatris that is specific to Spain. Regulatory requirements, data protection requirements and practices or medical practices may differ between countries, and therefore the information provided on this page may not be suitable for use in all countries.
    Cancel
    Continue to country page

    Localized information for

    The page you are about to visit contains information about Viatris that is specific to . Regulatory requirements, data protection requirements and practices or medical practices may differ between countries, and therefore the information provided on this page may not be suitable for use in all countries.
    Cancel
    Continue to country page

    Welcome to

    Viatris
    Mylan is now part of Viatris, a new global pharmaceutical company committed to empowering people to live healthier at every stage of life. We encourage you to learn more about our commitment to increasing access to quality medicines for patients when and where they need them.
    Explore Viatris

    Leaving the Viatris site

    You are now leaving the Viatris page for a Viatris affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Viatris affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

    Continue
    Cancel

    Breadcrumb

    1. Investors

    November 7, 2022
    at 8:30 AM EST

    Third Quarter 2022 Financial Results

    Webcast

    Supporting Materials

    Strategic Update Press Release 264.1 KB
    Strategic Update Presentation 1.4 MB
    Press Release
    Q3 2022 Earnings Presentation 920.5 KB
    Q3 2022 Non-GAAP Reconciliations 364.3 KB

    Footer Links Column1

    • Viatris Privacy Notice
    • Cookie Notice
    • Terms of use

    Footer Links Column2

    • Contact Us
    • California Supplemental Disclosure
    • California Supply Chain Transparency, UK and Australia Modern Slavery Statement

    Footer Links Column3

    • Sitemap
    • About Us
    • Products

    Footer Links Column4

    • Careers
    • Investors
    • Newsroom
    • Cookies Preferences
    • Follow Us
    ©2023 Viatris Inc. All Rights Reserved.
    The Viatris logo is a registered trademark of Mylan Inc, a Viatris company.